Cargando…

Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study

BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia in patients with hypertension. ELABELA, which has cardioprotective effects, is decreased in the plasma of patients with hypertension and might be associated with AF in the hypertensive population. This study aims to measure the ELABELA plas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zheng, Zhao, Lei, Zhang, Ye-ping, Zhong, Jiu-chang, Yang, Xin-chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359615/ https://www.ncbi.nlm.nih.gov/pubmed/34384364 http://dx.doi.org/10.1186/s12872-021-02197-x

Ejemplares similares

Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
por: Ma, Zheng, et al.
Publicado: (2021)

Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome
por: DU, Sheng-Li, et al.
Publicado: (2020)

The Elabela-APJ axis: a promising therapeutic target for heart failure
por: Ma, Zheng, et al.
Publicado: (2020)

ELABELA acts as a protective biomarker in patients with atrial fibrillation
por: Cui, Chunhong, et al.
Publicado: (2021)

Association between ELABELA Serum Concentrations in First Trimester and Pregnancy-Induced Hypertension
por: Ma, Shujuan, et al.
Publicado: (2020)

Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022)

The Expression Levels of Plasma micoRNAs in Atrial Fibrillation Patients
por: Liu, Zheng, et al.
Publicado: (2012)

The Impact of Hypertension and Atrial Fibrillation on Cognitive Decline and Subclinical Atherosclerosis
por: Militaru, Marius, et al.
Publicado: (2021)

Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy
por: Georgiadou, Danai, et al.
Publicado: (2019)

Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation?
por: Wang, Juan, et al.
Publicado: (2018)

Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
por: Acele, Armağan, et al.
Publicado: (2020)

Sexual Dimorphism in the Polarization of Cardiac ILCs through Elabela
por: Salles, Évila Lopes, et al.
Publicado: (2022)

Advances in the study of ELABELA in renal physiological functions and related diseases
por: Liu, YuRong, et al.
Publicado: (2023)

Elabela Protects Spontaneously Hypertensive Rats From Hypertension and Cardiorenal Dysfunctions Exacerbated by Dietary High-Salt Intake
por: Sainsily, Xavier, et al.
Publicado: (2021)

ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
por: Pritchard, Natasha, et al.
Publicado: (2018)

Serum elabela and apelin levels during different stages of chronic kidney disease
por: Lu, Xuehong, et al.
Publicado: (2020)

Increased Elabela levels in the acute ST segment elevation myocardial infarction patients
por: Dönmez, Yurdaer, et al.
Publicado: (2019)

Elabela prevents angiotensin II-induced apoptosis and inflammation in rat aortic adventitial fibroblasts via the activation of FGF21–ACE2 signaling
por: Song, Juan-Juan, et al.
Publicado: (2021)

Elabela-Apelin Receptor Signaling Pathway is Functional in Mammalian Systems
por: Wang, Zhi, et al.
Publicado: (2015)

Interaction of apelin, elabela and nitric oxide in schizophrenia patients
por: Catak, Zekiye, et al.
Publicado: (2020)

MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling
por: Song, Juan-Juan, et al.
Publicado: (2020)

Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?
por: Onalan, Erhan, et al.
Publicado: (2020)

A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension
por: Rozwadowski, Jan, et al.
Publicado: (2022)

The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021)

Incidence and risk factors of post-operative cognitive decline after ablation for atrial fibrillation
por: Zhang, Jing, et al.
Publicado: (2021)

The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis
por: Helker, Christian SM, et al.
Publicado: (2015)

Uma Nova Via para Oclusão Coronariana com Elabela?
Publicado: (2021)

Elabela gene therapy promotes angiogenesis after myocardial infarction
por: Jin, Liangli, et al.
Publicado: (2021)

Elabela and Apelin regulate coronary angiogenesis in a competitive manner
por: A. Madiha, Syeda, et al.
Publicado: (2023)

Predicting late‐onset preeclampsia by detecting ELABELA content using an immunochromatographic colloidal gold test strip: Blood ELABELA content predicts the risk of pre‐eclampsia
por: Yang, Na, et al.
Publicado: (2023)

Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
por: Ding, Mozhu, et al.
Publicado: (2018)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
por: Nakase, Taizen, et al.
Publicado: (2023)

Brain lesions and cognitive decline in patients with atrial fibrillation
por: Hennings, E, et al.
Publicado: (2023)

Atrial fibrillation and frailty
por: Guo, Qi, et al.
Publicado: (2020)

Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice
por: Xu, Feng, et al.
Publicado: (2020)

Decreased plasma musclin levels are associated with potential atrial fibrillation in non-diabetic patients
por: Zhong, Yuan, et al.
Publicado: (2021)

ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway
por: Chen, Zhida, et al.
Publicado: (2020)

Anticoagulation in atrial fibrillation and cognitive decline: A systematic review and meta-analysis
por: Zeng, Decai, et al.
Publicado: (2019)

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
por: Acik, Didar Yanardag, et al.
Publicado: (2019)

Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure
por: Sunjaya, Anthony P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2qetpp995kgigfm4fmsa6ch7o1